Navigation Links
Applikon and Finesse Solutions Introduce TruConnect(TM)
Date:2/29/2008

SANTA CLARA, Calif., Feb. 29 /PRNewswire/ -- Finesse Solutions, LLC and Applikon Biotechnology Inc, announced the general release of the TruConnect(TM) gateway, a migration device designed to provide an interface between Applikon ADI 1010 and ADI 1030 Controllers, and the Finesse TruLogic(TM) Controller, enabled by Finesse's TruBio(TM) software (based on DeltaV(TM) control.)

TruConnect(TM) gateways harmonize an installed base of different ADI bioreactor controllers onto the same DeltaV(TM) control system platform. This harmonization can be made in phases, in order to lower budgetary costs and operating risk by leveraging three versions of TruBio(TM) software: TruBio(TM) Monitor for data collection only; TruBio(TM) SCADA for supervisory control; and TruBio(TM) OS for truly "active" control.

With TruBio(TM) software, end users can reduce their operators' learning curve with a uniform, intuitive user interface, increase flexibility with an open, fully configurable system, and improve efficiency with save/load replication of set-points and control loop parameters.

Applikon's President, John Chory, stated "The collaboration with Finesse has enabled us to ensure our customers that their substantial investment in our control products over the years can be easily migrated to an Applikon supported DeltaV solution whenever they require."

About Finesse Solutions, LLC

California-based Finesse Solutions, LLC, leads the way in developing new measurement and control technologies, in order to enable the transition to single-use systems, bring new capabilities to existing bioreactor platforms, and harmonize global bio-process information transfer. Our current product family provides comprehensive measurement and control solutions for upstream processes in the biotech and pharmaceutical industries. For more information, please visit us at http://www.finesse.com

About Applikon

Applikon is a privately owned Netherlands based company of which the Biotechnology division develops, manufactures and supplies bioreactor and control systems for research, pilot scale, and production. Founded in 1973, Applikon has grown into a global enterprise capable of supplying a broad and diverse line of bioreactor and control systems. Applikon autoclavable bioreactor systems are the worldwide industry standard. Applikon controllers comply with the highest standards applied in the pharmaceutical industry. AppliSens, owned by Applikon, presents sensors and perfusion systems for application in bio-processes under GMP conditions.

Applikon is headquartered in Schiedam, the Netherlands, with major operations in Foster City (USA), Eckington (UK), and in more than 12 countries. For more information refer to http://www.applikon.com.


'/>"/>
SOURCE Finesse Solutions, LLC
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. John OConnell Joins Finesse Solutions as Vice-President of Sales and Business Development
2. Toxic Neglect: Mutual Funds Opposing Shareholder Resolutions on Chemicals in Products Ignore Financial Risks to Shareholders
3. Plexus Systems, Inc. Names Stosz to Solutions Engineer
4. WallSt.net (www.wallst.net) Updates Investment Community Through All-New Interview With digiMedical Solutions
5. Hospira Announces New Contract With HealthTrust Purchasing Group for Infusion Devices, Solutions and Equipment
6. Video: YMCAs Commit to Helping Americans Keep Their New Years Resolutions in Support of Health and Well-Being
7. SXC Health Solutions Corp. to acquire National Medical Health Card Systems, Inc.
8. Elsevier enhances clinical decision making with suite of Clinical Decision Support solutions
9. Harris Corporation Demonstrates Digital Signage(TM) Solutions for Dynamic, Rapid Communications within Healthcare Enterprises
10. Colubris Demonstrates Wide-Ranging Mobility Solutions for Healthcare
11. Antares Management Solutions Earns Top ISO Re-Certification
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/31/2016)... ... , ... Dr. Charles A. Ditta attained his Doctor of Medical Dentistry Degree ... 1986, where he graduated in the top ten percentile of his class. Dr. Ditta ... He has been a member in good standing for thirty years in the American ...
(Date:5/31/2016)... ... May 31, 2016 , ... ... on patients with cancer, has added Cancer and Careers to its ... more timely content on continuing successful careers while fighting cancer. , As partners, ...
(Date:5/30/2016)... ... May 30, 2016 , ... ... inside of FCPX," said Christina Austin - CEO of Pixel Film Studios. ... within Final Cut Pro X. Choose from abstract transitions to more simple wipes ...
(Date:5/30/2016)... Texas (PRWEB) , ... May 30, 2016 , ... Another ... 7 am in Plano, located at 3960 Legacy Drive, Plano, TX and is open ... Plano Chamber of Commerce followed by a medical open house. The Jasper High School ...
(Date:5/29/2016)... Viejo, CA (PRWEB) , ... May 29, 2016 , ... ... Volume 3 let's the user control the style of their project," said Christina Austin ... set of 30 self-animating web-themed intros created exclusively for use in Final Cut Pro ...
Breaking Medicine News(10 mins):
(Date:5/31/2016)... -- , Isansys  Lifecare, a new generation digital ... wireless patient monitoring platform, as it ships more systems to ... , Scotland and Norway ... system, launched earlier this year, is now being used in ... This new technology significantly enhances the user experience and ...
(Date:5/30/2016)... 2016 According to a ... Market by Type (Stability, Raw Materials, Method Validation, ... (Pharmaceutical Companies, Medical Device Companies) - Global Forecast ... healthy growth during the last decade and is ... between 2016 and 2021 to reach USD 4.13 ...
(Date:5/30/2016)... , May 30, 2016 Eye expert ... of premature babies to seek an eye examination ... condition     Moorfields Eye Hospital Dubai, ... London , has identified premature babies as a ... because of their particular vulnerability to retinopathy of prematurity (ROP). ROP ...
Breaking Medicine Technology: